Effector Mechanisms of Rejection

Archive ouverte

Moreau, Aurélie | Varey, Emilie | Anegon, Ignacio | Cuturi, Maria-Cristina

Edité par CCSD ; Cold Spring Harbor Laboratory Press -

International audience. Organ transplantation appears today to be the best alternative to replace the loss of vital organs induced by various diseases. Transplants can, however, also be rejected by the recipient. In this review, we provide an overview of the mechanisms and the cells/molecules involved in acute and chronic rejections. T cells and B cells mainly control the antigen-specific rejection and act either as effector, regulatory, or memory cells. On the other hand, nonspecific cells such as endothelial cells, NK cells, macrophages, or polymorphonuclear cells are also crucial actors of transplant rejection. Last, beyond cells, the high contribution of antibodies, chemokines, and complement molecules in graft rejection is discussed in this article. The understanding of the different components involved in graft rejection is essential as some of them are used in the clinic as biomarkers to detect and quantify the level of rejection.

Suggestions

Du même auteur

Preclinical Assessment of Autologous Tolerogenic Dendritic Cells From End-stage Renal Disease Patients

Archive ouverte | Bouchet-Delbos, Laurence | CCSD

International audience. Background: Kidney transplantation is the therapeutic of choice for patients with kidney failure. While immunosuppressive drugs can control graft rejection, their use is associated with incre...

Cell therapy using tolerogenic dendritic cells in transplantation

Archive ouverte | Moreau, Aurélie | CCSD

International audience. Organ transplantation is the main alternative to the loss of vital organ function from various diseases. However, to avoid graft rejection, transplant patients are treated with immunosuppress...

Cell therapy using tolerogenic dendritic cells in transplantation.

Archive ouverte | Moreau, Aurelie | CCSD

International audience. Organ transplantation is the main alternative to the loss of vital organ function from various diseases. However, to avoid graft rejection, transplant patients are treated with immunosuppress...

Chargement des enrichissements...